2,6-Diketopiperazines from amino acids, from solution-phase to solid-phase organic synthesis.

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Heterocyclic Chemistry

Background:

• 2,6-diketopiperazines (2,6-DKP) are valuable heterocyclic scaffolds.
• Developing efficient synthetic routes for diverse 2,6-DKP libraries is crucial for drug discovery.
• Existing methods may have limitations in scope, yield, or purity.

Purpose of the Study:

• To describe a novel synthetic method for preparing 1,3-disubstituted 2,6-diketopiperazines.
• To demonstrate the applicability of this method in both solution-phase and solid-phase synthesis.
• To enable the parallel synthesis of diverse and pure 2,6-DKP libraries for drug lead identification.

Main Methods:

• Intramolecular cyclization of a secondary amide nitrogen onto a benzyl ester under basic conditions.
• Utilizing a Wang resin carboxylic ester for solid-phase synthesis, enabling simultaneous cyclization and cleavage ('cyclocleavage').
• Employing iterative conditions on solid phase to maintain high diastereoisomeric purity.

Main Results:

• The method successfully synthesized various 1,3-disubstituted 2,6-DKP compounds using different amino acid pairs, irrespective of configuration.
• Parallel synthesis of a series of fully characterized compounds was achieved.
• Diastereoisomer content was consistently maintained below detection limits (<0.1% by HPLC and 1H NMR).

Conclusions:

• The described synthetic strategy provides a robust and versatile platform for generating diverse 2,6-DKP libraries.
• The solid-phase approach offers advantages in purification and scalability for drug discovery efforts.
• This method facilitates the efficient production of high-purity heterocyclic scaffolds for identifying new drug leads.